Chiesi, Research and Development
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
Silver nanowire interactions with primary human alveolar type-II epithelial cell secretions: contrasting bioreactivity with human alveolar type-I and ... - Nanoscale (RSC Publishing) DOI:10.1039/C5NR01496D
Curosurf
Κωδικός Συσκ. ΕΟΦ Ονο
Service Customer Service Patientservice Medical Suggestions Pharmacovigilance data privacy/ cookies Products Sustainability Our approach We ACT - Sustainability Manifesto Environment Supply Chain Sustainability Ethics and Transparency ...
Ioannis Gianniotis - Medical Representative - Chiesi Hellas | LinkedIn
Chiesi Hellas
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
Curosurf ® 120 mg/240 mg
Pa O 2 after surfactant lavage in Infasurf, KL4-Surfactant, Exosurf and... | Download Scientific Diagram
Chiesi Hellas | LinkedIn
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
Ioannis Gianniotis - Medical Representative - Chiesi Hellas | LinkedIn
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
Chiesi Farmaceutici completes the acquisition of European Marketing Rights
Influence of surfactant preparations on proliferation ability of... | Download Scientific Diagram
PDF) Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
About Chiesi Our history Mission and Values Οικονομικές Καταστάσεις Disclosure Annual and Sustainability Report B Corp Pharmacovigilance Therapeutic areas Respiratory Neonatology Rare Diseases Contacts Product Portfolio Respiratory Neonatology ...
